Videos related to the International Finance Facility for Immunisation (IFFIm).
05 June 2020
IFFIm puts long-term donor pledges to work immediately by making Vaccine Bonds available on the world’s capital markets. This frees funds up immediately to help our partners deliver life-saving vaccines without having to wait for pledged donations to come in incrementally, over time.
01 February 2019
IFFIm is at the cutting edge of socially responsible investing for global health. Built upon partnerships with Gavi, the World Bank and donor countries, IFFIm raises money through Vaccine Bonds, providing immediate funding for Gavi's work in helping immunise the world's poorest children. [French]
07 February 2019
IFFIm gives investors a unique opportunity to realise an attractive, secure rate of return while saving young lives, too. Countries benefit from private sector capital investment. Fast, flexible funding can be directed toward immediate needs, local health system strengthening, vaccination campaigns and unexpected emergencies. [French]
When a sovereign donor makes a legally binding pledge to IFFIm, it is paid in annual tranches over a period of years or decades. But by issuing Vaccine Bonds on international capital markets, IFFIm can make the full donor pledge available immediately so Gavi can immunise more children, faster. [French]
20 September 2012
The IFFIm-GAVI partnership for immunisation [Japanese]
Discover how IFFIm uses the bond markets to fund immunisation faster.
08 June 2012
The IFFIm-Gavi partnership for immunisation
Discover how IFFIm uses the bond markets to fund immunisation faster. [Japanese]
01 June 2011
Investment cases - Yellow fever
Amidst political uncertainty, UNICEF supports yellow-fever immunization campaign in Côte d'Ivoire.
Investment cases - Health system strengthening
A short video reporting on the vital role that health workers play in rural communities in Vietnam.
Gavi and IFFIm - The Aid Traders
The International Finance Facility for Immunisation, (IFFIm) is credited with saving more three million children's lives by delivering basic vaccines. But how does it work, how much does it cost and is it right to take money from future aid budgets to deliver vaccines today?
IFFIm supporting Gavi
See how IFFIm's “vaccine bonds” fund immunisation.
14 February 2011
Pneumococcal vaccine global launch
The rollout of pneumococcal vaccines in the developing world is underway across three continents. Nicaragua, Honduras, Guyana, Sierra Leone, Yemen, Kenya, Democratic Republic of the Congo and Mali are the first Gavi-eligible countries that are in the process of rolling out pneumococcal vaccines in 2010 and 2011.
Kenya pneumococcal launch ceremony
Watch highlights from the pneumococcal launch ceremony at Kenya’s International Conference Centre.
12 December 2010
Nicaragua pneumococcal launch
Highlights from the pneumococcal launch ceremony in Nicaragua, including the speech by Helen Evans, Deputy CEO, Gavi, the Vaccine Alliance.
19 October 2010
Interview with Simon Bland, DFID, during the launch of the pneumococcal vaccine in Kenya
Simon Bland talks about Gavi's life saving mission on the occasion of the pneumococcal vaccine launch in Nairobi, Kenya.
Joint project with China leads to dramatic fall in hepatitis B infections
At the start of the new millennium, the Chinese government's efforts to immunise newborn children against the deadly consequences of hepatitis B (hepB) infection were struggling to overcome formidable physical and economic barriers posed by the country's poorest provinces.
20 September 2010
Margaret Chan, Millennium Development Goals Summit
WHO's Margaret Chan has an important message for donors.
Andrew Mitchell, DFID, Millennium Development Goals Summit
Andrew Mitchell, UK Secretary of State for International Development, explains why his department, DFID, supports the GAVI Alliance.
Amie Batson, USAID, Millennium Development Goals Summit
Amie Batson, Deputy Assistant Administrator of USAID, talks about the need for creative new approaches.
08 June 2009
Gavi pneumococcal AMC
Pneumococcal disease is one of the biggest vaccine preventable killers of children today, but now, thanks to the Advance Market Commitment (AMC), that's all about to change.